Current management of the vascular subtype of Ehlers-Danlos syndrome

Keyphrases

• Current Management 100%
• Ehlers-Danlos Syndrome 100%
• Life Expectancy 33%
• Tertiary Care Hospital 16%
• Disease Progression 16%
• Clinical Features 16%
• Interdisciplinary Health Team 16%
• Improved Outcomes 16%
• Surgical Management 16%
• Medical Therapy 16%
• Molecular Diagnostics 16%
• Consensus Guidelines 16%
• Severe Disease 16%
• Natural History 16%
• Enhanced Awareness 16%
• General Practitioners 16%
• Intervention Therapy 16%
• Medical Intervention 16%
• Endovascular Techniques 16%
• Interventionalist 16%
• Rapid Diagnosis 16%
• Type III Collagen 16%
• Medical Geneticist 16%
• Multidisciplinary Effort 16%
• Average Life Expectancy 16%
• New Consensus 16%
• Celiprolol 16%
• Vessel Rupture 16%

Medicine and Dentistry

• Ehlers Danlos Syndrome 100%
• Life Expectancy 50%
• Awareness 33%
• Energy-Dispersive X-Ray Spectroscopy 33%
• Clinical Feature 16%
• Disease Exacerbation 16%
• Combination Therapy 16%
• Patient Referral 16%
• Excitement 16%
• Molecular Diagnosis 16%
• Diagnostic Procedure 16%
• Medical Intervention 16%
• General Practitioner 16%
• Blood Vessel Rupture 16%
• Celiprolol 16%
• Collagen Type 3 16%
• Surgery 16%